成血小板物质 thrombon
形成血小板血栓 platelet plug
合成血小板一氧化氮 platelet-derived nitric oxide ; PDNO
合成富血小板胶 PRGEL
抗血栓形成药[血小板聚集抑制剂]的有害效应 Adverse effects in therapeutic use, antithrombotic drugs
采集一品脱血液后，将其加工成可输血的成分：血浆、血小板和红细胞。
After a pint of blood is collected, it is processed into its transfusible components: plasma, platelets and red blood cells.
CD39可以磷酸化水解ATP成ADP，而ADP是血小板激活和聚集的主要激动剂，所以CD39具有抗血小板的作用。
CD39 is phosphohydrolysing ATP and ADP, noting that ADP is the major agonist for platelet activation and aggregation, so CD39 has a pretty similar mechanism to antiplatelet therapies.
它们都常规的在血液中循环。纤维蛋白原转变成不可溶的丝状的蛋白质——纤维蛋白，纤维蛋白限制血小板的运动并且使血小板连接成“被子”以止血。
In particular they round up cellular fragments called platelets, and also molecules of a soluble protein called fibrinogen, both of which circulate routinely in the bloodstream.
应用推荐